SmallCapVoice (@smallcapvoice) header
SmallCapVoice (@smallcapvoice) profile picture

Investor Relations, Communications, & Media | 25+ Years of Compliant IR Practices | Do Your Own Due Diligence | Disclaimer: https://xitter.gq/t.co/4gsISV5hKY

Joined June 2009
Photo by SmallCapVoice (@smallcapvoice)Photo by SmallCapVoice (@smallcapvoice)Photo by SmallCapVoice (@smallcapvoice)Photo by SmallCapVoice (@smallcapvoice)Photo by SmallCapVoice (@smallcapvoice)Photo by SmallCapVoice (@smallcapvoice)Photo by SmallCapVoice (@smallcapvoice)Photo by SmallCapVoice (@smallcapvoice)Photo by SmallCapVoice (@smallcapvoice)Photo by SmallCapVoice (@smallcapvoice)
Four posters at SITC 2026 bring new preclinical data from BriaCell ($BCTX) and BriaPro. Highlights include Bria-OTS+ immune activation across multiple tumor models, a 49-fold increase in PD-L1 binding for TILsRx-001, and a CD80 variant showing over 130-fold stronger binding. Read the full release: globenewswire.com/news-relea…
3
11
374
KULR Q3 2026 Earnings Call Announced KULR Technology Group (NYSE American: KULR) is scheduled to report its third quarter 2026 financial results on Tuesday, November 10, followed by a conference call at 8:30 AM ET. Management will discuss the Company's quarterly financial performance and business developments. 📅 Tuesday, November 10, 2026 🕣 8:30 AM ET / 5:30 AM PT 🔗 For more information and to register for the earnings call, click here: kulr.ai/kulr-technology-grou…
3
10
395
BriaCell ($BCTX ) has been named BioTech Breakthrough’s 2026 “Immunotherapy Solution of the Year” as its lead candidate, Bria-IMT, advances through a pivotal Phase 3 study for metastatic breast cancer. Phase 2 median survival reached 13.3–16.6 months vs. historical benchmarks of 5.9–9.8 months. Read the full PR: globenewswire.com/news-relea…
7
19
470
Things are taking shape at Global Entertainment Holdings (OTC: $GBHL). Following its finalized business combination with PYX Wallets, CEO Ryan Contardi joins SmallCapVoice to discuss the company's smart wallet technology, market opportunity, and key milestones on the path to commercialization. Watch the interview: youtube.com/watch?v=LodvcSqK…
8
6
27
1,926
BriaCell (NASDAQ: $BCTX ) reports preclinical results showing its Bria-OTS+ immunotherapy platform activated immune cells and stimulated tumor-cell killing across breast, prostate and lung cancer models. Four research presentations from BriaCell and BriaPro are scheduled for SITC 2026. Read the full PR: globenewswire.com/news-relea…
7
15
475
A key milestone for $HYOR as it advances its first commercial waste-to-methanol module toward Portugal deployment. Independent lab testing measured 75.43% combined hydrogen and carbon monoxide in RDF-derived syngas, with just 0.76% nitrogen. Initial methanol production in Portugal is now targeted for Q1 2027. Read more about the results and deployment timeline: globenewswire.com/news-relea…
4
14
382
BriaCell Therapeutics (NASDAQ: $BCTX) CEO Dr. William Williams is featured in a new Pulse 2.0 interview discussing cancer immunotherapy and off-the-shelf cancer vaccines. Explore the latest media coverage: briacell.com/media-coverage/
5
20
455
$HYOR is targeting a major step toward industrial scale waste to methanol production in Europe: a proposed 150 TPD facility in Portugal, with installation planned to begin in 2028. The roadmap includes a 35 TPD expansion backed by ~€6.7M in EU STEP funding and a production cost target of €350 per tonne. Read SmallCapVoice’s latest article on HyOrc’s European expansion: smallcapvoice.com/hyorc-corp…
4
7
332
ICYMI: $IQST is targeting a $1B revenue run rate, with the pending Ultranet acquisition projected to push revenue to $700M to $750M while higher margin digital services support its path to profitability. Hear CEO Leandro Iglesias and CFO Álvaro Cardona break down the strategy: globenewswire.com/news-relea…
6
11
478
How can WhatsApp integration accelerate SalesCloser’s international growth? CEO Ali Tajskandar joins SmallCapVoice to discuss AI sales agents, new customer acquisition, multilingual capabilities, and the company’s expanding multi-channel platform. Watch the interview now: youtu.be/OJd4nV4OM0Q $SCAI $SCTLF
7
1
20
653
$MITI appoints Frank Panunto to its Board, adding a real estate executive with 30 years of franchise operations experience and 1,000+ real estate transactions. Panunto has also advised on RoboAgent development for nearly two years, bringing direct project experience to the Board. Read more: globenewswire.com/news-relea…
5
16
362
Featured in The American Journal of Managed Care: BriaCell’s investigational Bria-IMT is in Phase 3 testing for metastatic breast cancer after ADC treatment. Phase 2 data showed median overall survival of 16.6 months. Read the feature here: briacell.com/media-coverage/ $BCTX
6
17
522
AI sales agents are expanding to WhatsApp. $SCAI $SCTLF SalesCloser’s AI agents can now respond to leads in seconds, 24/7, using each business’s own services, pricing and hours, with built in human handoff. Read the latest on SalesCloser’s expanding platform: globenewswire.com/news-relea…
6
19
407
$IQST is targeting a $1B revenue run rate, with management projecting $700M to $750M following the proposed Ultranet acquisition. Hear CEO Leandro Iglesias and CFO Álvaro Cardona discuss the growth strategy: youtube.com/watch?v=v1KQ9u8t…
7
1
20
774
IQSTEL Closes Two‑Year Non‑Convertible Financing for Ultranet, a Profitable $131 Million‑Revenue West African Telecom Platform Expected to Make IQSTEL Cash‑Flow Positive on a Consolidated Basis We’ll have an interview with $IQST coming out tomorrow, but for now, read the full press release here: nasdaq.com/press-release/iqs…
9
1
21
685
$BCTX presented new data at ESMO 2026 showing CAML PD-L1 measured approximately 3 months after immunotherapy was significantly associated with both progression free and overall survival in metastatic breast cancer. The 111 patient analysis supports further study of this potential biomarker, including with the Bria-IMT regimen. Read more: globenewswire.com/news-relea…
6
15
384
Dr. William Williams, CEO of $BCTX, joins The Bio Report podcast to discuss “Developing an Off-the-Shelf Cell-Based Immunotherapy for Metastatic Breast Cancer.” Listen to the interview and explore more BriaCell media coverage: briacell.com/media-coverage/
3
1
20
550
Stonegate Capital’s report on HyOrc ( OTCQB: $HYOR ) highlights the company’s waste to methanol technology, growing commercial pipeline, and Portugal project. The report offers insight into the company’s strategy and progress toward commercial validation. Read the report: stonegateinc.com/wp-content/… #OTCQB #CleanTech #GreenMethanol #WasteToEnergy #EnergyTransition #MicroCaps #Investing
6
15
343
Why Does $HYOR Target Hard to Electrify Sectors? Watch the full interview for more! 🔗 Watch the full video: youtu.be/A0xEy1YmByU #Sustainability #Decarbonization #CleanEnergy #Innovation #GreenTech
4
6
354